We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONN
851
DELISTED
Conn's Inc.
CONN
| $528K | ﹤0.01% |
20,695
-47,830
| -70% | -$1.1M |
|
|
SREV
852
DELISTED
ServiceSource International, Inc.
SREV
| $528K | ﹤0.01% |
374,507
+86,031
| +30% | +$113K |
|
853
Crinetics Pharmaceuticals
CRNX
$8.86B
| $525K | ﹤0.01% |
27,839
-45,317
| -62% | -$796K |
|
|
NFBK
854
DELISTED
Northfield Bancorp
NFBK
| $523K | ﹤0.01% |
+31,899
| New | +$525K |
|
855
Brinker International
EAT
$8.02B
| $518K | ﹤0.01% |
+8,371
| New | +$529K |
|
|
EIGR
856
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $511K | ﹤0.01% |
2,000
-3,558
| -64% | -$888K |
|
|
STXB
857
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $509K | ﹤0.01% |
22,287
+3,295
| +17% | +$76.2K |
|
858
Aligos Therapeutics
ALGS
$25.2M
| $507K | ﹤0.01% |
+996
| New | +$635K |
|
859
Merck
MRK
$324B
| $503K | ﹤0.01% |
6,465
-396,671
| -98% | -$29.5M |
|
|
HALL
860
DELISTED
Hallmark Financial Services, Inc.
HALL
| $496K | ﹤0.01% |
11,139
-21,258
| -66% | -$886K |
|
861
American Eagle Outfitters
AEO
$2.85B
| $495K | ﹤0.01% |
+13,201
| New | +$457K |
|
|
DSKE
862
DELISTED
Daseke, Inc. Common Stock
DSKE
| $494K | ﹤0.01% |
76,195
+36,929
| +94% | +$268K |
|
|
PGRE
863
DELISTED
Paramount Group
PGRE
| $491K | ﹤0.01% |
48,733
-493
| -1% | -$5.25K |
|
864
Aldeyra Therapeutics
ALDX
$91.7M
| $488K | ﹤0.01% |
43,069
| – | – |
|
865
Equity Lifestyle Properties
ELS
$12.8B
| $486K | ﹤0.01% |
6,534
-190,558
| -97% | -$13.5M |
|
866
Marchex
MCHX
$79.7M
| $485K | ﹤0.01% |
158,365
+8,248
| +5% | +$23K |
|
|
IMGN
867
DELISTED
Immunogen Inc
IMGN
| $483K | ﹤0.01% |
73,329
+29,905
| +69% | +$209K |
|
868
NextCure
NXTC
$17.3M
| $478K | ﹤0.01% |
4,962
-1,455
| -23% | -$149K |
|
869
ePlus
PLUS
$2.33B
| $474K | ﹤0.01% |
+10,932
| New | +$522K |
|
870
Parsons
PSN
$6.28B
| $473K | ﹤0.01% |
+12,020
| New | +$494K |
|
|
871
Intercontinental Exchange
ICE
$82.4B
| $471K | ﹤0.01% |
3,966
-500,172
| -99% | -$57.6M |
|
872
BCB Bancorp
BCBP
$176M
| $470K | ﹤0.01% |
34,934
+18,158
| +108% | +$251K |
|
|
HNGR
873
DELISTED
Hanger Inc.
HNGR
| $469K | ﹤0.01% |
18,539
-76,349
| -80% | -$1.9M |
|
874
Evergy
EVRG
$20.1B
| $467K | ﹤0.01% |
+7,724
| New | +$483K |
|
875
Granite Construction
GVA
$5.45B
| $466K | ﹤0.01% |
+11,215
| New | +$445K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.